The filing of a beefed-up Code of Ethics raises concerns. Checking the web sites of other companies where S-T sits on the board, Questcor and Regernerx, the codes of ethics look like standard stuff, so it doesn't appear that S-T insists on spelling out the details like this. The new SciClone code has a section specifically on bribery and spells out forbidding bribing to "advance our interests with government authorities." The concern is if this new code is in response to such bribery especially if it has anything to do with the business in China. Bribery seems to be all too common in China, but the Chinese government makes a showcase of when they prosecute. A couple years ago they executed the head of the SFDA for taking bribes and made big news about it. The bribers probably didn't get much better treatment. If SciClone screwed up, what could the Chinese do to the company? Revoke its ability to import Zadaxin? You know the local manufacturers of generic thymosin would love that! If Blobel would positively assure investors that the company knows of no instance of company bribery that would help. If he can't say that, there could be big trouble.